Protein misfolding and aggregation

蛋白质错误折叠和聚集

• 批准号: 7588931
• 负责人: NIKOLAY DOKHOLYAN
• 金额: $ 28.18万
• 依托单位: UNIV OF NORTH CAROLINA CHAPEL HILL
• 依托单位国家: 美国
• 财政年份: 2007
• 资助国家: 美国
• 起止时间: 2007-04-01 至 2012-03-31
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/7588931
• 关键词: Adult; Amyotrophic Lateral Sclerosis; Anti-Inflammatory Agents; Anti-inflammatory; Appearance; Back; Biophysics; Cell Death; Cells; Centrifugation; Collaborations; Computational Biology; Computer Simulation; Coupled; Cuprozinc Superoxide Dismutase; Defect; Development; Developmental Cell Biology; Diflunisal; Disease; Dissociation; Electron Microscopy; Environment; Enzymes; Equilibrium; Familial Amyotrophic Lateral Sclerosis; Feedback; Goals; Inherited; Joints; Laboratory Study; Lead; Letters; Life; Light; Mediating; Metals; Methodology; Modeling; Molecular Chaperones; Molecular Conformation; Molecular Sieve Chromatography; Monitor; Motion; Motor Neurons; Mutation; Neurodegenerative Disorders; Neurosciences; Patients; Pharmaceutical Preparations; Prealbumin; Protein Dynamics; Proteins; Reaction; Research; Research Personnel; Speed; Structure; Study models; Surface; Surface Plasmon Resonance; Testing; Therapeutic; Work; Zinc; aggregation pathway; amyloid fibril formation; amyloidogenesis; analog; analytical ultracentrifugation; base; computer studies; cytotoxic; cytotoxicity; dimer; feeding; light scattering; molecular dynamics; monomer; mutant; neuron loss; novel; novel strategies; novel therapeutic intervention; programs; protein aggregation; protein misfolding; research study; sedimentation equilibrium; simulation; small molecule

DESCRIPTION (provided by applicant): Protein aggregation is frequently observed in neurodegenerative diseases, including the most common adult motor neuron disease, Amyotrophic Lateral Sclerosis (ALS). In familial ALS (FALS), 20% of patients inherit mutations in the dimeric enzyme Cu, Zn superoxide dismutase (SOD1) associated with increased formation of SOD1 aggregates that contribute to the cytotoxicity responsible for motor neuron cell death and underlying FALS. Our goal is to understand the mechanism of SOD1 aggregation. Accomplishing this goal may be a key step for the development of new FALS therapies, and will impact our understanding of over 60 additional aggregation-associated diseases. Our central hypothesis is that SOD1 aggregation is caused by the increased formation of unfolded/misfolded monomeric species, and/or defects in chaperone-mediated refolding. Specifically, we postulate that mutations (in case of FALS), fluctuations in cell environment and expression levels increase SOD1 dimer dissociation, loss of zinc, and/or the rate of formation of aggregates. We will therefore determine effects of FALS mutations, metals, on the mechanism of SOD1 aggregation. We will characterize the large-scale dynamics of a single SOD1 dimer in rapid computer simulations. We will assess the impact of FALS-associated mutations on SOD1 aggregation by examining the dynamics of mutant and wild type SOD1 molecules using novel multi-scale protein models for studies of large-scale protein conformational dynamics. We will also characterize the large-scale oligomerization dynamics of multiple SOD1 molecules in computer simulations of multiple SOD1 molecules and follow their oligomerization. We will assess the impact of FALS-associated mutations on SOD1 aggregation by examining the dynamics of mutant and wild type SOD1 molecules. For each step of aggregation reaction sequence we will experimentally determine rate and equilibrium constants using size exclusion chromatography, surface plasmon resonance, analytical ultracentrifugation, dynamic light scattering, electron microscopy, and computation. Results from experimental studies will be fed back to computational studies for validating and refining computational models. In turn, computational modeling will guide experimental work. RELEVANCE: Mechanistic understanding of SOD1 agggregation will provide a framework for understanding the origin and for developing treatments for this and other neurodegenerative diseases.

描述（由申请人提供）：在神经退行性疾病中经常观察到蛋白质聚集，包括最常见的成人运动神经元疾病，肌萎缩性侧索硬化症（ALS）。在家族性ALS（FALS）中，20%的患者遗传了二聚酶Cu，Zn超氧化物歧化酶（SOD 1）的突变，该突变与SOD 1聚集体的形成增加相关，SOD 1聚集体有助于引起运动神经元细胞死亡和潜在的FALS的细胞毒性。我们的目标是了解SOD 1聚集的机制。实现这一目标可能是开发新的FALS疗法的关键一步，并将影响我们对60多种其他聚集相关疾病的理解。我们的中心假设是，SOD 1聚集是由未折叠/错误折叠的单体种类的形成增加，和/或伴侣介导的重折叠缺陷引起的。具体来说，我们假设突变（在FALS的情况下），细胞环境和表达水平的波动增加SOD 1二聚体解离，锌的损失，和/或聚集体形成的速率。因此，我们将确定FALS突变，金属，对SOD 1聚集机制的影响。我们将在快速计算机模拟中描述单个SOD 1二聚体的大规模动力学。我们将通过使用新的多尺度蛋白质模型研究大规模蛋白质构象动力学来研究突变型和野生型SOD 1分子的动力学，评估与SOD 1聚集相关的突变对SOD 1聚集的影响。我们还将在多个SOD 1分子的计算机模拟中表征多个SOD 1分子的大规模寡聚动力学，并跟踪其寡聚化。我们将通过研究突变型和野生型SOD 1分子的动态来评估与SOD 1聚集相关的突变对SOD 1聚集的影响。对于聚集反应序列的每一步，我们将通过实验确定速率和平衡常数，使用尺寸排阻色谱法，表面等离子体共振，分析超离心，动态光散射，电子显微镜和计算。实验研究的结果将反馈到计算研究中，以验证和改进计算模型。反过来，计算建模将指导实验工作。相关性：对SOD 1聚集的机制理解将为理解其起源和开发这种和其他神经退行性疾病的治疗方法提供框架。